SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059360
Filing Date
2018-11-13
Accepted
2018-11-13 16:12:05
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv506647_10q.htm 10-Q 399201
2 EXHIBIT 31.1 tv506647_ex31-1.htm EX-31.1 7329
3 EXHIBIT 31.2 tv506647_ex31-2.htm EX-31.2 7405
4 EXHIBIT 32.1 tv506647_ex32-1.htm EX-32.1 3665
5 EXHIBIT 32.2 tv506647_ex32-2.htm EX-32.2 3821
  Complete submission text file 0001144204-18-059360.txt   5776447

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20180930.xml EX-101.INS 1789078
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20180930.xsd EX-101.SCH 34980
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20180930_cal.xml EX-101.CAL 31548
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20180930_def.xml EX-101.DEF 269702
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20180930_lab.xml EX-101.LAB 311978
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20180930_pre.xml EX-101.PRE 307814
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 181178078
SIC: 2834 Pharmaceutical Preparations